Clinical Trials Directory

Trials / Completed

CompletedNCT02561351

Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Mahidol University · Academic / Other
Sex
All
Age
7 Years – 20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine mean or median of fractional exhaled nitric oxide (FeNO) in Thai atopic asthmatic children that divided into subgroups due to asthma exacerbation according to the global initiative for asthma guideline.

Detailed description

From many previous studies, fractional exhaled nitric oxide (FeNO) has many benefits such as non-invasive, easily to perform, less time consume, has direct association with severity of inflammation of bronchial trees and sputum eosinophils, has benefit for diagnosis and monitoring the treatment in asthmatic patients. In Thailand, this field of study is less extend, especially in children population. The investigators hypothesized that patients with asthma exacerbation may have high level of fractional exhaled nitric oxide (FeNO) than non exacerbation group. It is therefore desirable to examine the association between fractional exhaled nitric oxide (FeNO) and asthma exacerbation among atopic asthmatic Thai children and will be the main objective of this research.

Conditions

Interventions

TypeNameDescription
OTHERFeNO measurementFeNO was performed repeatedly every 3 months in every cases. exacerbations were recorded each visit

Timeline

Start date
2013-09-01
Primary completion
2015-09-01
Completion
2015-09-01
First posted
2015-09-28
Last updated
2016-05-03

Source: ClinicalTrials.gov record NCT02561351. Inclusion in this directory is not an endorsement.